Korlym (mifepristone) — Point32Health
hyperglycemia secondary to endogenous Cushing’s disease in adults with type 2 diabetes or glucose intolerance
Initial criteria
- Documented diagnosis of hyperglycemia secondary to endogenous Cushing’s disease
- AND Documented diagnosis of type 2 diabetes or glucose intolerance
- AND Patient age ≥ 18 years
- AND Prescribing physician is an endocrinologist
- AND Documentation that surgery (e.g., pituitary, adrenal) is not an option OR has not been curative
Reauthorization criteria
- Documented diagnosis of hyperglycemia secondary to endogenous Cushing’s disease
- AND Documented diagnosis of type 2 diabetes or glucose intolerance
- AND Patient age ≥ 18 years
- AND Prescribing physician is an endocrinologist
- AND Documentation of improved or stable glucose tolerance
Approval duration
initial 3 months; reauth 12 months